Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations
Toshiro Ogura(Tokyo Medical and Dental University), Kiwamu Akagi(Kuwait University), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Yoji Nishimura(Saitama Cancer Center), Minoru Tanabe(Tokyo Institute of Technology), Yoichi Tanaka(Saitama Cancer Center), Miho Kakuta(Saitama Cancer Center), Hirohiko Sakamoto(Saitama Cancer Center), Toshimasa Yatsuoka(Saitama Cancer Center)
Cited by 37
Related Papers
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
|Nature Genetics|2013|476
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277